IPO - Aptorum Group Ltd

Form Type: 424B5

Filing Date: 2025-01-03

Corporate Action: Ipo

Type: New

Accession Number: 000121390025000606

Filing Summary: Aptorum Group Limited is offering an aggregate of 1,535,000 Class A Ordinary Shares at a public offering price of $2.00 per share, amounting to $3,070,000. The offering is conducted under a Securities Purchase Agreement dated January 2, 2025, with Maxim Group LLC acting as the placement agent, who will receive a fee of 7.0% on the total proceeds. The current market value of the company's Class A Ordinary Shares held by non-affiliates amounts to approximately $9.67 million. The company aims to utilize the proceeds from this offering to support the development of its therapeutic and diagnostic projects, including lead projects ALS-4, SACT-1, and the PathsDx Test. Previously, the firm had paused R&D activities to focus on a potential merger with YOOV Group, which was terminated, prompting a search for new business combination opportunities. Significant investment risks are noted, particularly due to the nature of the company being a Cayman Islands holding company with operations in various jurisdictions. Delivery of the shares is expected on January 3, 2025, subject to customary closing conditions.

Document Link: View Document